Replication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019
Motives and side-effects of microdosing with psychedelics among users
Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | International Journal of Neuropsychopharmacology | 31 May 2019
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults
Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019
The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis
Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019
Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users
Ona, G., Kohek, M., Massaguer, T., Gomariz, A., Jiménez, D. F., Dos Santos, R. G., & Bouso, J. C. | Journal of psychoactive drugs | 7 February 2019
A Jamesian Response to Reductionism in the Neuropsychology of Religious Experience
Kime, K. G., & Snarey, J. R. | Archive for the Psychology of Religion | 13 December 2018
Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. | Pharmacology & therapeutics | 4 December 2018
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
Domínguez-Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., ... & Riba, J. | Psychopharmacology | 7 November 2018
Dimensions of consciousness and the psychedelic state
Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018
Psychedelics, Meditation, and Self-Consciousness
Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F. M., & Berkovich-Ohana, A. | Frontiers in psychology | 4 September 2018
Legitimate Medicine in the Age of Consumerism
Lamkin, M. | 21 August 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Are Ecstasy Induced Serotonergic Alterations Overestimated For The Majority Of Users?
Szigeti, B., Winstock, A. R., Erritzoe, D., & Maier, L. J. | Journal of Psychopharmacology | 7 May 2018
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018
Psychedelic Naturalism and Interspecies Alliance: Views from the Emerging Do-It-Yourself Mycology Movement
Steinhardt, J. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
Peyote’s Race Problem
Dawson, A. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study
Dorsen, C., Palamar, J., & Shedlin, M. G. | Addiction Research & Theory | 30 March 2018
Psychedelics: Where we are now, why we got here, what we must do
Belouin, S. J., & Henningfield, J. E. | Neuropharmacology | 21 February 2018
Psychiatry & the psychedelic drugs. Past, present & future.
Rucker, J. J., Iliff, J., & Nutt, D. J. | Neuropharmacology | 25 December 2017
Perceptions of the medicinal value of hallucinogenic drugs among college students
Wildberger, J. I., John, C. N., & Hallock, R. M. | Journal of Psychedelic Studies | 17 October 2017
The relationships of classic psychedelic use with criminal behavior in the United States adult population
Hendricks, P. S., Crawford, M. S., Cropsey, K. L., Copes, H., Sweat, N. W., Walsh, Z., & Pavela, G. | Journal of Psychopharmacology | 1 October 2017
Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
Argento, E., Strathdee, S. A., Tupper, K., Braschel, M., Wood, E., & Shannon, K. | BMJ open | 21 September 2017
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Sessa, B. | Psychopharmacology | 23 August 2017
Constructing drug effects: A history of set and setting
Hartogsohn, I. | Drug Science, Policy and Law | 1 January 2017